Cerebral Cortical Encephalitis in Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease
Annals of Neurology · 2023-02 · 93 (2) · 297-302
DOI: 10.1002/ana.26549 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Annals of Neurology, online erschienen am 02.12.2022. Verfasst von Cristina Valencia-Sanchez und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mayo Clinic, Scottsdale, AZ, USA. Hauptthemen laut MEDLINE: Encephalitis. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Cerebral cortical encephalitis (CCE) is a recently described myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) phenotype. In this observational retrospective study, we characterized 19 CCE patients (6.7% of our MOGAD cohort). Headache (n = 15, 79%), seizures (n = 13, 68%), and encephalopathy (n = 12, 63%) were frequent. Magnetic resonance imaging revealed unilateral (n = 12, 63%) or bilateral (n = 7, 37%) cortical T2 hyperintensity and leptomeningeal enhancement (n = 17, 89%). N‐Methyl‐D‐aspartate receptor autoantibodies coexisted in 2 of 15 tested (13%). CCE pathology (n = 2) showed extensive subpial cortical demyelination (n = 2), microglial reactivity (n = 2), and inflammatory infiltrates (perivascular, n = 1; meningeal, n = 1). Most received high‐dose steroids (n = 17, 89%), and all improved, but 3 had CCE relapses. This study highlights the CCE spectrum and provides insight into its pathogenesis. ANN NEUROL 2023;93:297–302
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Mayo Clinic, Scottsdale, AZ, USA.
- Department of Neurology and Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA.
- Department of Radiology, Mayo Clinic, Rochester, MN, USA.
- Department of Ophthalmology, Mayo Clinic, Rochester, MN, USA.
- Department of Neurology, University of Florida, Gainesville, FL, USA.
- Brooke Army Medical Center, San Antonio, TX, USA.
ORCID-Profile: Cristina Valencia-Sanchez, Sebastian Lopez-Chiriboga, Adrian Budhram, Divyanshu Dubey, Sean J Pittock
Förderung
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Valencia-Sanchez, C., Guo, Y., Krecke, K. N., Chen, J. J., Redenbaugh, V., Montalvo, M., Elsbernd, P. M., Tillema, J. M., Lopez-Chiriboga, S., Budhram, A., Sechi, E., Kunchok, A., Dubey, D., Pittock, S. J., Lucchinetti, C. F., & Flanagan, E. P. (2023). Cerebral Cortical Encephalitis in Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease. Annals of Neurology, 93(2), 297-302. https://doi.org/10.1002/ana.26549
Vancouver
Valencia-Sanchez C, Guo Y, Krecke KN, Chen JJ, Redenbaugh V, Montalvo M, et al. Cerebral Cortical Encephalitis in Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease. Annals of Neurology. 2023;93(2):297-302. doi:10.1002/ana.26549
BibTeX
@article{ValenciaSanchez2023,
author = {Valencia-Sanchez, Cristina and Guo, Yong and Krecke, Karl N and Chen, John J and Redenbaugh, Vyanka and Montalvo, Mayra and Elsbernd, Paul M and Tillema, Jan-Mendelt and Lopez-Chiriboga, Sebastian and Budhram, Adrian and Sechi, Elia and Kunchok, Amy and Dubey, Divyanshu and Pittock, Sean J and Lucchinetti, Claudia F and Flanagan, Eoin P},
title = {Cerebral Cortical Encephalitis in Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease},
journal = {Annals of Neurology},
year = {2023},
volume = {93},
number = {2},
pages = {297--302},
doi = {10.1002/ana.26549}
}
EUVIMED